Motor Neurone Disease

Gene: ALS2

Green List (high evidence)

ALS2 (ALS2, alsin Rho guanine nucleotide exchange factor)
EnsemblGeneIds (GRCh38): ENSG00000003393
EnsemblGeneIds (GRCh37): ENSG00000003393
OMIM: 606352, Gene2Phenotype
ALS2 is in 11 panels

2 reviews

Sangavi Sivagnanasundram (Melbourne Health)

Green List (high evidence)

>10 individuals from 4 unrelated families with ALS

PMID: 24562058
Identified homozygous truncating mutation with parents confirmed to be unaffected heterozygous carriers. 
2 unrelated consanguineous families 
Individuals had muscle weakness and muscle biopsy showing angular atrophic fibres with a dystonia phenotype and profound muscle atrophy

PMID: 11586298
>8 individuals from two unrelated families with ALS2 mutations and ALS phenotypes
Created: 17 May 2023, 10:26 a.m. | Last Modified: 17 May 2023, 10:26 a.m.
Panel Version: 0.138

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Amyotrophic lateral sclerosis 2, juvenile (MIM# 205100; MONDO: MONDO:0008780)

Publications

Teresa Zhao (Victorian Clinical Genetics Services)

Green List (high evidence)

>50 variants reported in multiple individuals with Infantile onset ascending spastic paralysis, mostly originated from the Middle East and Mediterranean countries.
Sources: Literature
Created: 17 Aug 2021, 11:48 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Infantile onset ascending spastic paralysis (MIM#607225); Juvenile amyotrophic lateral sclerosis 2 (MIM#205100); Juvenile primary lateral sclerosis (MIM#606353)

Publications

History Filter Activity

16 Oct 2025, Gel status: 3

Removed Source, Removed Source, Removed Source, Added New Source, Set Phenotypes, Set publications

Chirag Patel (Genetic Health Queensland)

Source Literature was removed from ALS2. Source Melbourne Genomics Health Alliance Complex Neurology Flagship was removed from ALS2. Source Victorian Clinical Genetics Services was removed from ALS2. Source ClinGen was added to ALS2. Phenotypes for gene: ALS2 were changed from Amyotrophic lateral sclerosis 2, juvenile (MIM# 205100; MONDO: MONDO:0008780) to ALS2-related motor neuron disease, MONDO:0100227 Publications for gene ALS2 were changed from 30128655, 33409823, 11586298, 16240357, 23282280, 24562058, 33155358 to 30128655, 33409823, 11586298, 16240357, 23282280, 24562058, 33155358

30 May 2023, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: als2 has been classified as Green List (High Evidence).

30 May 2023, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: ALS2 were changed from to Amyotrophic lateral sclerosis 2, juvenile (MIM# 205100; MONDO: MONDO:0008780)

30 May 2023, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: ALS2 were set to

30 May 2023, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: ALS2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: ALS2 was added gene: ALS2 was added to Motor neuron disease MND_MelbourneGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Complex Neurology Flagship Mode of inheritance for gene: ALS2 was set to Unknown